NASDAQ: RGEN
Repligen Corporation
Healthcare · Medical - Instruments & Supplies
After hours: $169.00(+1.99%) · as of 4:19 PM ET
Market Cap
$9.35B
52w High
$175.77
52w Low
$100.99
P/E
226.02
Volume
0.00
Outstanding Shares
56.44M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 36.49% over the last year. Revenue grew 16.49% over the trailing twelve months. Operating margin moved from -3.54% to 8.32%. Free cash flow grew 4.56% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 43rd percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at 8.32%. Revenue grew 16.49% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
22
Buy
2
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Oct 27, 2026
Q4 FY26 · EPS est $0.46 · Revenue est $206.8M
View